Defining high, medium and low impact prognostic factors for developing multiple sclerosis-Reference-Cited by-同舟云学术

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

Published:2015-04-21 Issue:7 Volume:138 Page:1863-1874
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:Brain

Author:

Tintore Mar,Rovira Àlex,Río Jordi,Otero-Romero Susana,Arrambide Georgina,Tur Carmen,Comabella Manuel,Nos Carlos,Arévalo María Jesús,Negrotto Laura,Galán Ingrid,Vidal-Jordana Angela,Castilló Joaquin,Palavra Filipe,Simon Eva,Mitjana Raquel,Auger Cristina,Sastre-Garriga Jaume,Montalban Xavier

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/138/7/1863/13799773/awv105.pdf

Reference36 articles.

1. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

2. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

3. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

4. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

5. Age at disability milestones in multiple sclerosis

Cited by 426 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prominence of Oligoclonal Bands for clinical conversion in Radiologically isolated syndrome: 10-year follow-up study in Isfahan, Iran;Clinical Neurology and Neurosurgery;2024-10

2. Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up;Multiple Sclerosis and Related Disorders;2024-09

3. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores;Neurology Neuroimmunology & Neuroinflammation;2024-09

4. Fluid biomarkers in multiple sclerosis: from current to future applications;The Lancet Regional Health - Europe;2024-09

5. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis;The Lancet Regional Health - Europe;2024-09